Premier Biomedical, Inc. (OTCMKTS:BIEI) Sees Significant Growth in Short Interest

Premier Biomedical, Inc. (OTCMKTS:BIEI) was the recipient of a significant growth in short interest in the month of August. As of August 14th, there was short interest totaling 560,542 shares, a growth of 49,027.3% from the July 30th total of 1,141 shares. Based on an average daily volume of 30,713,332 shares, the days-to-cover ratio is currently 0.0 days.

Premier Biomedical Price Performance

Shares of Premier Biomedical stock remained flat at $0.00 during mid-day trading on Tuesday. 54,000 shares of the stock traded hands, compared to its average volume of 19,638,213. Premier Biomedical has a twelve month low of $0.00 and a twelve month high of $0.00.

About Premier Biomedical

Premier Biomedical, Inc, a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer's disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries.